0001179110-20-007718.txt : 20200623
0001179110-20-007718.hdr.sgml : 20200623
20200623161430
ACCESSION NUMBER: 0001179110-20-007718
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200619
FILED AS OF DATE: 20200623
DATE AS OF CHANGE: 20200623
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Seely Lynn
CENTRAL INDEX KEY: 0001327111
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37359
FILM NUMBER: 20982049
MAIL ADDRESS:
STREET 1: 501 2ND STREET
STREET 2: SUITE 211
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Blueprint Medicines Corp
CENTRAL INDEX KEY: 0001597264
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 45 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-374-7580
MAIL ADDRESS:
STREET 1: 45 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
FORM 4 -
X0306
4
2020-06-19
0
0001597264
Blueprint Medicines Corp
BPMC
0001327111
Seely Lynn
C/O BLUEPRINT MEDICINES CORPORATION
45 SIDNEY STREET
CAMBRIDGE
MA
02139
1
0
0
0
Common Stock
2020-06-19
4
M
0
1312
A
1312
D
Restricted Stock Units
2020-06-19
4
M
0
1312
0
D
Common Stock
1312
0
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
On June 19, 2019, the reporting person was granted 1,312 restricted stock units. These restricted stock units are fully vested.
/s/ Christopher Frankenfield, Attorney-in-Fact
2020-06-23